We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEN icon
1001
Compugen
CGEN
$224M
– –
-18,850
Closed -$120K
CMU
1002
DELISTED
MFS High Yield Municipal Trust
CMU
– –
-15,426
Closed -$70K
CNS icon
1003
Cohen & Steers
CNS
$4.18B
– –
-18,497
Closed -$564K
CPA icon
1004
Copa Holdings
CPA
$5.61B
– –
-10,058
Closed -$485K
CPSS icon
1005
Consumer Portfolio Services
CPSS
$202M
– –
-180,972
Closed -$939K
CSV icon
1006
Carriage Services
CSV
$628M
– –
-18,745
Closed -$452K
CTLP
1007
DELISTED
Cantaloupe
CTLP
– –
-32,837
Closed -$101K
CTS icon
1008
CTS Corp
CTS
$1.68B
– –
-84,949
Closed -$1.5M
CUBI icon
1009
Customers Bancorp
CUBI
$2.65B
– –
-10,510
Closed -$286K
CVGW
1010
DELISTED
Calavo Growers
CVGW
– –
-21,422
Closed -$1.05M
CVLG icon
1011
Covenant Logistics
CVLG
$1.11B
– –
-139,032
Closed -$1.31M
DAN icon
1012
Dana Inc
DAN
$2.89B
– –
-383,059
Closed -$5.29M
DBRG icon
1013
DigitalBridge
DBRG
$2.94B
– –
-105,839
Closed -$5.14M
DENN
1014
DELISTED
Denny's
DENN
– –
-180,582
Closed -$1.77M
DHC
1015
Diversified Healthcare Trust
DHC
$2.25B
– –
-28,202
Closed -$419K
DIOD icon
1016
Diodes
DIOD
$3.82B
– –
-77,375
Closed -$1.78M
DMF
1017
DELISTED
BNY Mellon Municipal Income
DMF
– –
-16,624
Closed -$157K
DVAX
1018
DELISTED
Dynavax Technologies
DVAX
– –
-10,788
Closed -$261K
ENPH icon
1019
Enphase Energy
ENPH
$4.79B
– –
-12,999
Closed -$46K
EYPT icon
1020
EyePoint Inc
EYPT
$1.03B
– –
-2,513
Closed -$121K
FATE icon
1021
Fate Therapeutics
FATE
$281M
– –
-32,495
Closed -$110K
FELE icon
1022
Franklin Electric
FELE
$4.63B
– –
-67,724
Closed -$1.83M
FET icon
1023
Forum Energy Technologies
FET
$643M
– –
-1,846
Closed -$460K
FIVN icon
1024
FIVE9
FIVN
$1.9B
– –
-18,302
Closed -$159K
FIX icon
1025
Comfort Systems
FIX
$58.7B
– –
-20,283
Closed -$576K
39 40
41
42 43

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.